STADA Is Investing Another 20 Million Euros in the Production Capacity of Hemofarm in Vršac
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
German pharmaceutical group STADA continues to invest heavily in this part of Europe. The company has approved a new investment worth 20 million euros in Hemofarm's production facilities in Vršac, Serbia. The investment was approved by the Global Executive Board of the STADA Group, and should enable an increase in production and the development of new production capacities of one of the largest pharmaceutical systems in the region. The announcem…
Biznis i Finansije
STADA Group CEO Peter Goldschmidt announced today that STADA will invest another 20 million euros in production capacity in Vršac and added that Serbia has become a center for... The article STADA invests another 20 million euros in the production capacity of Hemofarm in Vršac appeared first on Biznis i Finansije.
BELGRADE: STADA Group CEO Peter Goldschmidt announced today that STADA will invest another 20 million euros in production capacities in Vršac and added that Serbia has become a center for international jobs within the STADA Group.
The general director of Stada Group, Peter Goldschmidt, announced in Belgrade that the pharmaceutical company will invest 20 million euros in the construction of a new production line in its Hemofarm factory in Vršac in 2027. Goldschmidt said at a press conference in Belgrade that the investment had just been approved,...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
